Stay updated with breaking news from Bivalent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK CITY (dpa-AFX) - Drug major Pfizer Inc. (PFE) and German partner BioNTech SE (BNTX) announced Friday updated data from a Phase 2/3 clinical trial for Omicron BA.4/BA.5-adapted bivalent
MRNA-1273.222 targets BA.4/BA.5 Omicron subvariants and follows the approval of mRNA-1273.214 (SPIKEVAX Bivalent) in Canada, which targets the Omicron BA.1 subvariantCAMBRIDGE, MA / ACCESSWIRE / November
Dr Jane Rudy EXPOSES The Truth About DEADLY Bivalent Boosters: DR JANE RUDY EXPOSES THE TRUTH ABOUT DEADLY BIVALENT BOOSTERS: WATCH
NEW YORK CITY (dpa-AFX) - Drug major Pfizer Inc. (PFE) announced Tuesday positive top-line data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus or RSV
THE STAR – Malaysia will receive an updated form of COVID-19 vaccine manufactured by Pfizer-BioNTech this month, said Health Minister Khairy Jamaluddin. “The original vaccine is effective against Omicron and the XBB (sub-variant). However, I would like to inform you that Malaysia has placed orders for the bivalent vaccine from Pfizer,” he said at a […]